ConductScience.org, home

Paper40148397

An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines.

Karamifard F and 2 others. Sci Rep, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines. Papers, record 40148397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40148397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines.
PubMed
Journal
Sci Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-05-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Karamifard FFaranakhttps://orcid.org/0000-0001-6165-5164
2Dadbinpour AAlihttps://orcid.org/0000-0003-3627-9472
3Mazaheri MMahtahttps://orcid.org/0000-0003-4164-3400

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HexokinaseMajor topic
Breast NeoplasmsMajor topic
PeptidesMajor topic
Humans
Apoptosis
Cell Proliferation
Female
Cell Line, Tumor
MCF-7 Cells

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136335239A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors.Sci Rep2022https://conductscience.org/library/papers/36335239PubMed
237576816A review of FDA approved drugs and their formulations for the treatment of breast cancer.Front Pharmacol2023https://conductscience.org/library/papers/37576816PubMed
331934028The correlation between autophagy and tamoxifen resistance in breast cancer.Int J Clin Exp Pathol2019https://conductscience.org/library/papers/31934028PubMed
436858045What is cancer metabolism?Cell2023https://conductscience.org/library/papers/36858045PubMed
538017510Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells.Stem Cell Res Ther2023https://conductscience.org/library/papers/38017510PubMed
638255739Protein-Protein Interactions of Seryl-tRNA Synthetases with Emphasis on Human Counterparts and Their Connection to Health and Disease.Life (Basel)2024https://conductscience.org/library/papers/38255739PubMed
736939199Molecular principles of tissue invasion and metastasis.Am J Physiol Cell Physiol2023https://conductscience.org/library/papers/36939199PubMed
839001477Is Cancer Metabolism an Atavism?Cancers (Basel)2024https://conductscience.org/library/papers/39001477PubMed
938090058Prediction of death rates for cardiovascular diseases and cancers.Cancer Innov2023https://conductscience.org/library/papers/38090058PubMed
1035400351Studies of cell-penetrating peptides by biophysical methods.Q Rev Biophys2022https://conductscience.org/library/papers/35400351PubMed
1136715303Computational approaches for the design of modulators targeting protein-protein interactions.Expert Opin Drug Discov2023https://conductscience.org/library/papers/36715303PubMed
1239334905VDAC1-Based Peptides as Potential Modulators of VDAC1 Interactions with Its Partners and as a Therapeutic for Cancer, NASH, and Diabetes.Biomolecules2024https://conductscience.org/library/papers/39334905PubMed
1337779156Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37779156PubMed
1434277705Peptide Based Inhibitors of Protein Binding to the Mitogen-Activated Protein Kinase Docking Groove.Front Mol Biosci2021https://conductscience.org/library/papers/34277705PubMed
1531426130Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer.Cancer Med2019https://conductscience.org/library/papers/31426130PubMed
1638981701Pore-Forming VDAC Proteins of the Outer Mitochondrial Membrane: Regulation and Pathophysiological Role.Biochemistry (Mosc)2024https://conductscience.org/library/papers/38981701PubMed
1731364685Self-assembly of mitochondria-specific peptide amphiphiles amplifying lung cancer cell death through targeting the VDAC1-hexokinase-II complex.J Mater Chem B2019https://conductscience.org/library/papers/31364685PubMed
1837572183Does Boric Acid Inhibit Cell Proliferation on MCF-7 and MDA-MB-231 Cells in Monolayer and Spheroid Cultures by Using Apoptosis Pathways?Biol Trace Elem Res2024https://conductscience.org/library/papers/37572183PubMed
1938542116Targeting the Warburg Effect in Cancer: Where Do We Stand?Int J Mol Sci2024https://conductscience.org/library/papers/38542116PubMed
2033654335Method development in interaction polymer chromatography.Trends Analyt Chem2020https://conductscience.org/library/papers/33654335PubMed

See all 37 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42789163Antibiotic-chemotherapy interaction in brain tumors: cefazolin reduces chemotherapeutic efficacy of irinotecan in glioblastoma and neuroblastoma cells.Med Oncol2026https://conductscience.org/library/papers/42789163

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HK23099PubTator's text mininghttps://conductscience.org/library/genes/3099NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40148397

GET https://conductscience.org/api/papers/v1/40148397/references?page=2